BI Biotech India offers Plethora of Sensitive, Reliable and affordable Diagnostics Products that would provide rapid and accurate detection of Covid-19.



LEARN MORE

COVID-19 Diagnostics

  • Automated RNA extraction & Real time PCR Testing
    Fully automated real time sample to answer test for SARS-CoV-2 detection
  • High Throughput Multiplex SARS-CoV-2 testing
    It is a bead based multiplex RT-PCR testing for SARS-CoV-2 (detect upto 96 samples in 4 hours)
  • Respiratory Pathogen Panel
    Detects upto 20 other common respiratory pathogens
  • SARS-CoV-2 Multi Antigen IgG Assay
    One test to detect 3 antibodies against SARS-CoV-2 antigens

  • One step multiplex in vitro diagnostic kit for qualitative detection of N gene, OR1ab gene Rdrp gene of SARS-CoV-2
  • Compatible with the common RT-PCR Platforms
  • Ready Stock available

  • Highly sensitive point of care test kits for both IgM & IgG antibodies providing fast results in under 15 minutes

  • Room temperature viral stabilization formulation designed to maintain the optimum viability and virulence of the viral sample

  • Automated Extraction Cassettes
    Contain lysis and extraction reagents designed to rupture cells, extract nucleic acid, and remove inhibitors by magnetic nucleic acid capture particles.
  • Extraction kits
    Spin-column or magnetic bead format kits available for COVID-19 (SARS-CoV-2, Coronavirus) RNA Extraction- No phenol/chloroform extraction is required

BI biotech is committed for rapid dissemination Covid-19 research products and services of the highest standard to support our countries effort in combating this global outbreak.



LEARN MORE

COVID-19 Characterization

We provide complete solution for all your antibody needs, with Catalog of highly cited, validated antibodies against viral proteins; spike, nucleocapsid, envelope, ORF, and NSP.

Click here for list of molecules

Real-Time PCR tests are at the front lines of SARS-CoV-2 diagnostics. A range of supersensitive Reverse Transcriptases, Taq polymerases, dNTPs, and controls are available to meet the accuracy you need for every PCR assay.

Click here to learn more

To help speed up the generation of a vaccine against the Coronavirus. We offer ready-to-use primers & probes recognized from the United States Centres for Disease Control and Prevention (CDC) with their protocols recommended by the World Health Organization (WHO).

Click here to learn more

Quality recombinant proteins and enzymes with recorded bioactivity and consistent performance play an important role in studying SARS-CoV-2 & other coronaviruses.

Click here to learn more

Scientific research on biology of the virus as well as on new diagnostic and therapeutic means is a demanding, urgent task for both, academic institutions and pharmaceutical industry. To fulfil your urgent needs our principals have a very unique collection of stable cell lines related to coronavirus basic biology, including 293 cell lines overexpressing SARS-CoV-2 genes, immortalized alveoli cells, and cell lines for vaccine development

Click here to learn more

Human primary airway cells are available from nasal, tracheal and bronchial epithelia.

Advantages of using Human Primary Cells

  • A wide range of available donors give you access to primary cells from different genetic backgrounds and health status parameters (e.g. donors with COPD or asthma).
  • Access to cells from various tissue localizations (nasal, tracheal, bronchial, small airways).
  • A large stock inventory so you can plan multiple experiments using the same donor and media reagents.

Human primary airway cells are available from nasal, tracheal and bronchial epithelia.

Advantages of using Human Primary Cells

  • A wide range of available donors give you access to primary cells from different genetic backgrounds and health status parameters (e.g. donors with COPD or asthma).
  • Access to cells from various tissue localizations (nasal, tracheal, bronchial, small airways).
  • A large stock inventory so you can plan multiple experiments using the same donor and media reagents.

Product Lines

    • Human Nasal Epithelial Cells (HNEpC)
    • Human Tracheal Epithelial Cells (HTEpC)
    • Human Bronchial Epithelial Cells (HBEpC)
    • Human Small Airway Epithelial Cells (HSAEpC)

A range of immunoassay platforms for monitoring cytokine responses following SARS-CoV-2 infection are available. Whether you need qualitative or quantitative results, have limited or abundant sample, require single or multianalyte analysis, you will be able to find an optimal solution at for detecting cytokines in your samples

Click here to learn more

Custom Peptides & Substrate

Peptides play various roles in the Coronavirus physiology. Certain peptides can serve as substrates for the proteolytic machinery of the viral fusion system or have inhibitory roles in viral autophagy.

Click here to learn more

BI biotech is committed to provide our Indian researchers, Pharmaceuticals and Manufacturers with necessary products and service to aid in their efforts to develop vaccines and therapeutics to mitigate this global health crisis.



LEARN MORE

COVID-19 THERAPEUTIC DEVELOPMENT TOOLS General description of avaiblable diagnostics

When investigating COVID-19 it may be necessary to produce the individual proteins of SARS-CoV-2 or the host in a specific, controlled expression system. ACE2 and TMPRSS2 CRISPR knockout, HDR and Nickase knockout Plasmids, CRISPR Activation Plasmids, siRNA , shRNA Plasmids and shRNA lentiviral particles gene silencers are available for your extensive working.

Click here to learn more

 

Effective quality assurance, constant quality control and accurate results are key to therapeutics. We also have a huge catalogue of essential basic fine chemicals & reagents, cell culture media, drugs, inhibitors which will keep unstopped functioning of your lab.

Click here to learn

Libraries of bioactive compounds can also be screened with the aim of developing a novel therapeutic against COVID-19. The screening of anti-COVID-19 drugs by using the clinical and approved compounds can greatly shorten the research and development cycle. Our partner offers a library of 1280 fully annotated compounds for screening and identifying compounds that could target SARS-CoV-2

  • A unique collection of compounds having the potential of anti-SARS-CoV-2 activity, can be used for high
  • throughput screening and high content screening
  • Compounds ready-to-use in DMSO
  • Includes commonly used standards and the latest research tools, as well pharmacologically active
  • components of FDA-approved drug formulations
  • Low price for high quality, saving scientific research funds
  • With detailed compound information (structure, target, activity, value etc.)
  • Compounds available for re-supply

Subscribe Now